Haymaker Acquisition Corp. II files for a $300M SPAC IPO
by Kristi Marvin on 2019-05-21 at 7:42am

Monday night, the Haymaker team filed for their second SPAC with the $300 million Haymaker Acquisition Corp. II (HYACU).  “HYAC II” will be seeking to capitalize on their recent success with the OneSpaWorld deal, by once again focusing on consumer products and services, which plays to their background and strengths.  By all measures, Haymaker #1/OneSpaWorld was a big winner with the team closing that transaction in just over 15 months with the combined company now trading at ~$13.42.  But can they repeat that magic?

Well, this time around, Haymaker II is using 1/3 of a warrant rather than the 1/2 they used for their first SPAC. However, everything else about their structure is pretty much the same.  Even Cantor is back as underwriter.  However, there is one notable exception: This time, the underwriters are participating in the at-risk capital for Haymaker II, with Cantor purchasing $500,000 worth of warrants at $1.50 and Stifel, their advisor, is in for $100,000 worth of the total $8 million pool.  Is that meaningful? Not really.  That’s only 7.5%, whereas with other SPACs, it can sometimes reach as high as 30%.

However, Stifel, as an advisor, is interesting.  As we already know, Cantor does not like to share covers.  More often than not, they prefer to go it alone and would appear to reluctantly add co-leads or co-managers. As a matter of fact, since 2013 (when Cantor first got involved in SPACs), Cantor has had solo covers on 13 of their 22 completed deals, or 59% of them. So rather than an underwriter’s role, it would appear Stifel was given an advisor’s position instead.  Regardless, it’s a nice win for Stifel to be involved in whatever form it needed to take.

Additionally, in a bit of serendipity, the original CIBC Global Crossing team of Jay Bloom, Dean Kehler and Andrew Heyer, will have competing SPACs out searching for targets.  Jay Bloom and Dean Kehler, of Gx Acquisition Corp., priced their IPO last night at nearly the exact same time Andrew Heyer’s Haymaker II was making its first public filing.  Should make for a little sporting rivalry around the ol’ SPAC club, eh?…who’s going to bring the better deal?

However, to recap, Haymaker has stepped up their game and is now asking for 1/3 warrant instead of their previous 1/2 warrant. This feels “warranted”.  They completed Haymaker #1 in well under 24 months (~15 months) and their combination is trading around $13.40, so they’ve earned that 1/3 warrant.  They’ve shown they can deliver, so the expectation is they’ll repeat that success.

Summary of terms below:

haymaker ii terms

 

Recent Posts
by Nicholas Alan Clayton on 2025-06-05 at 8:25am

At the SPAC of Dawn Following yesterday’s ADP data reading showing that the US job market is cooling, the trading session is to begin today with an update on initial jobless claims, which had been expected to fall slightly. The market will also get trade deficit and productivity readouts before a pair of speeches by...

by Nicholas Alan Clayton on 2025-06-04 at 8:22am

At the SPAC of Dawn Space has been one of the most promising sectors for SPAC deals in recent years with four of the 14 de-SPACs that closed deals dating back to 2019 now trading above $10 and two of these above $20. A new company is about to test the traditional route to market,...

by Nicholas Alan Clayton on 2025-06-03 at 12:37pm

Quantumsphere (NASDAQ:QUMSU) has filed for a $60 million IPO with a team that has been steadily increasing its experience in SPACs through ties to several others in the Announced and Searching columns. The new SPAC is the second smallest that filed its first S-1 in the month of May and comes after 14-straight filings for...

by Nicholas Alan Clayton on 2025-06-03 at 8:21am

At the SPAC of Dawn Futures remain slightly red ever since the OECD downgraded global growth forecasts in light of the ongoing tariff disputes. This impact is anticipated to be felt most strongly in the US and Japan, although the later is expected to begin a rebound in 2026. This organization does not include African...

by Nicholas Alan Clayton on 2025-06-02 at 3:57pm

Crown Reserve Acquisition Corp. I (NASDAQ:CRACU) has filed for a $150 million IPO to seek out a biotech deal with a team tied to one of the busiest names in SPACs recently. The new SPAC was filed as something of a pair with Quantumsphere Acquisition Corporation (NASDAQ:QUMSU), which was also underwritten by SPAC Advisory Partners...

logo

Copyright © 2025 SPACInsider, Inc. All Rights Reserved